Currently out of the existing stock ratings of Steve Baxter, 346 are a HOLD (25.52%), 840 are a BUY (61.95%), 170 are a SELL (12.54%).

Steve Baxter

Work Performance Price Targets & Ratings Chart

Analyst Steve Baxter, currently employed at WELLS FARGO, carries an average stock price target met ratio of 64.23% that have a potential upside of 12.01% achieved within 99 days.

Steve Baxter’s has documented 137 price targets and ratings displayed on 15 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on AGL, agilon health at 15-Nov-2022.

Wall Street Analyst Steve Baxter

Analyst best performing recommendations are on MOH (MOLINA HEALTHCARE).
The best stock recommendation documented was for MOH (MOLINA HEALTHCARE) at 5/25/2022. The price target of $301 was fulfilled within 1 day with a profit of $13.68 (4.35%) receiving and performance score of 43.47.

Average potential price target upside

HUM Humana MOH Molina Healthcare OSCR Oscar Health AGL agilon health ANTM Anthem CI Cigna Corp CNC Centene Corp CVS CVS Health Corp CYH Community Health Systems HCA HCA Holdings UNH UnitedHealth Group orporated ELV Elevance Health TDOC Teladoc THC Tenet Healthcare UHS Universal Health Services

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$268

$20.9 (8.46%)

$261

1 months 17 days ago
(04-Nov-2024)

6/12 (50%)

$15.01 (5.93%)

237

Hold

$260

$12.9 (5.22%)

$400

2 months 10 days ago
(11-Oct-2024)

11/18 (61.11%)

$1.93 (0.75%)

188

Hold

$250

$2.9 (1.17%)

$250

2 months 12 days ago
(09-Oct-2024)

14/19 (73.68%)

$4.55 (1.85%)

232

Hold

$308

$60.9 (24.65%)

$599

2 months 13 days ago
(08-Oct-2024)

3/5 (60%)

$64.8 (26.64%)

142

Buy

$265

$17.9 (7.24%)

$400

2 months 13 days ago
(08-Oct-2024)

2/11 (18.18%)

$21.8 (8.96%)

95

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Steve Baxter?

On 2021

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?